dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 278201000202106

Production

add

Component

278201000202106

The component that hold information about this concept.

Fully Specified Name (FSN)

Faricimab (substance)

Shortest Term

Faricimab

Definition Status

900000000000074008 |Necessary but not sufficient concept definition status (core metadata concept)|

Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Summary

Faricimab (substance)

SCTID: 278201000202106, Primitive, Active

278201000202106|Faricimab (substance)|

en Faricimab
en Faricimab (substance)

Expression

278201000202106 |Faricimab (substance)|
 <<< 786911005 |Vascular endothelial growth factor receptor antagonist (disposition)| + 
712606001 |Monoclonal immunoglobulin g (substance)| + 
786910006 |Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)| + 
278191000202109 |Bispecific monoclonal antibody (substance)|

Diagram

Active

Component help	Language Code help	Type	Term help	Case Significance help	Acceptability	Active
5266541011 - Faricimab (en) View
5266541011	en	Synonym (core metadata concept)	Faricimab	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True
5266540012 - Faricimab (substance) (en) View
5266540012	en	Fully specified name (core metadata concept)	Faricimab (substance)	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True

Type help	Destination help	Relationship group help	Characteristic type help	Active
Relationship (15740403025) - 278201000202106 -> 712606001 (116680003) View
116680003 \|Is a (attribute)\|	712606001 \|Monoclonal immunoglobulin g (substance)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15740404020) - 278201000202106 -> 786910006 (116680003) View
116680003 \|Is a (attribute)\|	786910006 \|Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15740405021) - 278201000202106 -> 786911005 (726542003) View
726542003 \|Has disposition (attribute)\|	786911005 \|Vascular endothelial growth factor receptor antagonist (disposition)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (15744725028) - 278201000202106 -> 278191000202109 (116680003) View
116680003 \|Is a (attribute)\|	278191000202109 \|Bispecific monoclonal antibody (substance)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active
278191000202109 View
278191000202109	Bispecific monoclonal antibody (substance)	Bispecific monoclonal antibody	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True
786910006 View
786910006	Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)	Vegf antagonist	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
786911005 View
786911005	Vascular endothelial growth factor receptor antagonist (disposition)	Vegf antagonist	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True
712606001 View
712606001	Monoclonal immunoglobulin g (substance)	Monoclonal igg	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active

Reference Set help	Map Target help	Map Rule help	Map Advice help	Correlation help	Map Category help

Terminology chevron_right Concepts chevron_right 278201000202106

Descriptions

Relationships

Parent Concepts

Children Concepts

Extended Maps

Recent searches